CANY
TECX

Caxton Associates (New York)’s Tectonic Therapeutic TECX Stock Holding History

Caxton Associates (New York)’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,060
Closed -$141K – 747
2021
Q4 		$141K Buy
+3,060
New +$176K 0.01% 515

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Associates (New York)'s TECX Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 3,060 shares — an estimated $141K sold.

Caxton Associates (New York) first reported a position in TECX in Q4 2021 and held it in 1 quarter. The position peaked at $141K in Q4 2021. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,060 Tectonic Therapeutic shares in Q1 2022, an estimated $141K.
  • Caxton Associates (New York) first reported a position in Tectonic Therapeutic in Q4 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Tectonic Therapeutic position peaked at $141K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.